Trial Profile
A Clinical Study to Evaluate the Immunogenicity and Safety of Pandemic Influenza Vaccine, AdimFlu-W (H5N1), in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary) ; Aluminium hydroxide
- Indications Influenza A virus H5N1 subtype
- Focus Pharmacodynamics
- Sponsors Adimmune Corporation
- 12 Jul 2018 Status changed from recruiting to completed.
- 23 Jul 2012 New trial record